medigraphic.com
Instituto Nacional de Salud Pública

2020, Number 6

<< Back Next >>

salud publica mex 2020; 62 (6)

Quality of care in type 2 diabetes, progress and challenges from 2012 to 2018-19 for the Mexican health system

Flores-Hernández S, Acosta-Ruiz O, Hernández-Serrato MI, Delgado-Rodríguez S, Reyes-Morales H

Language: Spanish
References: 29
Page: 618-626
PDF size: 326.07 Kb.


ABSTRACT

Objective. To estimate changes in the quality of process of care and its association with glycaemic control in adults with type 2 diabetes. Materials and methods. Changes in compliance of 14 process of care indicators for 9 038 adults with type 2 diabetes and glycaemic control in a subsample were estimated. Averages, weighted changes and associations without or controlling for other factors were estimated using statistical weights for the combined data (Ensanut 2012 and Ensanut 2018-19). Results. From 2012 to 2018-19, glycaemic control doubled. Early detection of complications and increased insuline use improved, but identification and treatment of cardiovascular risk factors decreased. The overall quality of care was associated with optimal glycaemic control. Conclusions. There are areas of opportunity for improvement of quality of care, that deserve comprehensive strategies and continuous monitoring.


REFERENCES

  1. Hanefeld J, Powell-Jackson T, Balabanova D. Understanding and measuring quality of care: dealing with complexity. Bulletin World Health Organ. 2017;95(5):368-74. https://doi.org/10.2471/BLT.16.179309

  2. Rossi MC, Lucisano G, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, et al. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care. 2011;34(2):347-52. https://doi.org/10.2337/dc10-1709

  3. Stokes A, Berry KM, Mchiza Z, Parker WA, Labadarios D, Chola L, et al. Prevalence and unmet need for diabetes care across the care continuum in a national sample of South African adults: Evidence from the SANHANES-1, 2011-2012. PloS one. 2017;12(10):e0184264. https://doi. org/10.1371/journal.pone.0184264

  4. Khan MA, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes–Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107-11. https://doi. org/10.2991/jegh.k.191028.001

  5. Ackermann RT, Thompson TJ, Selby JV, Safford MM, Stevens M, Brown AF, et al. Is the number of documented diabetes process-of-care indicators associated with cardiometabolic risk factor levels, patient satisfaction, or self-rated quality of diabetes care?: The Translating Research into Action for Diabetes (TRIAD) study. Diabetes Care. 2006;29(9):2108-13. https:// doi.org/10.2337/dc06-0633

  6. Stone MA, Charpentier G, Doggen K, Kuss O, Lindblad U, Kellner C, et al. Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care. 2013;36(9):2628-38. https://doi.org/10.2337/ dc12-1759

  7. Pérez-Cuevas R, Doubova SV, Suarez-Ortega M, Law M, Pande AH, Escobedo J, et al. Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico. BMC Med Inform Decis Mak. 2012;(50):1-10. https://doi.org/10.1186/1472-6947-12-50

  8. Gutiérrez JP, García-Saisó S, Espinosa-de la Peña R, Balandrán DA. Desigualdad en indicadores de enfermedades crónicas y su atención en adultos en México: análisis de tres encuestas de salud. Salud Publica Mex 2016;58(6):666-75. https://doi.org/10.21149/spm.v58i6.7923

  9. Hernández-Romieu AC, Elnecavé-Olaiz A, Huerta-Uribe N, Reynoso- Noverón N. Análisis de una encuesta poblacional para determinar los factores asociados al control de la diabetes mellitus en México. Salud Publica Mex. 2011;53(1):34-9 [citado septiembre 19, 2020]. Disponible en: http://www.scielo.org.mx/pdf/spm/v53n1/06.pdf

  10. Flores-Hernández S, Saturno-Hernández PJ, Reyes-Morales H, Barrientos-Gutierrez T, Villalpando S, Hernández-Avila M. Quality of diabetes care: the challenges of an increasing epidemic in Mexico. Results from two national health surveys (2006 and 2012). PloS one. 2015;10(7):1-15. https://doi.org/10.1371/journal.pone.0133958

  11. Secretaría de Salud. Plan estratégico para la difusión e implementación de guías de práctica clínica. 2ª ed. México: SS, 2018 [citado septiembre 19, 2020]. Disponible en: http://www.calidad.salud.gob.mx/site/calidad/docs/ plan_estrategico_gpc.pdf

  12. Secretaría de Salud. Programa Sectorial de Salud 2013-2018. México: SS, 2013 [citado septiembre 19, 2020]. Disponible en: http://evaluacion. ssm.gob.mx/pdf/Prosesa-2013-2018.pdf

  13. Basto-Abreu A, Barrientos-Gutiérrez T, Rojas-Martínez R, Aguilar- Salinas CA, López-Olmedo N, De la Cruz-Góngora D, et al. Prevalencia de diabetes y descontrol glucémico en México: resultados de la Ensanut 2016. Salud Publica Mex. 2020;62(1):50-9. https://doi.org/10.21149/10752

  14. Romero-Martínez M, Shamah-Levy T, Franco-Núñez A, Villalpando S, Cuevas-Nasu L, Gutiérrez JP, et al. Encuesta Nacional de Salud y Nutrición 2012: diseño y cobertura. Salud Publica Mex. 2013;50(Suppl 2):S332-40 [citado septiembre 19, 2020]. Disponible en: http://www.scielo.org.mx/ scielo.php?script=sci_arttext&pid=S0036-36342013000800033

  15. Romero-Martínez M, Shamah-Levy T, Vielma-Orozco E, Heredia- Hernández O, Mojica-Cuevas J, Cuevas-Nasu L, et al. Encuesta Nacional de Salud y Nutrición 2018-19: metodología y perspectivas. Salud Publica Mex. 2019;61(6):917-23. https://doi.org/10.21149/11095

  16. Gutiérrez JP. Clasificación socioeconómica de los hogares en la Ensanut 2012. Salud Publica Mex. 2013;55(supl 2):S341-6. https://doi. org/10.21149/spm.v55s2.5133

  17. Anexo 1. Indicadores y criterios para medir la calidad en el proceso de atención aplicables a todos los adultos con diagnóstico de DT2. Disponible en: https://doi.org/10.6084/m9.figshare.13105478.v1

  18. American Diabetes Association. 6. Glycemic targets: Standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl1):S66-76. https:// doi.org/10.2337/dc20-S006

  19. Lee S, Davis WW, Nquyen HA, McNeel TS, Brick JM, Flores-Cervantes I. Examining trends and averages using combined cross-sectional survey data from multiple years. California Health Interview Survey. Methodology Paper 2007 [citado septiembre 19, 2020]. Disponible en: https://healthpolicy. ucla.edu/chis/faq/Documents/paper_trends_averages.pdf

  20. Anexo 2. Cambios en el porcentaje de adultos con DT2 en control glucémico entre 2012 y 2018. Modelo multivariable para estimación por indicadores de calidad en el proceso de atención en adultos con DT2, ajustado por otras covariables. Disponible en: https://doi.org/10.6084/ m9.figshare.13105484.v1

  21. American Diabetes Association. 9. Pharmacologic approaches: Standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Supp 1):S98-110. https://doi.org/10.2337/dc20-S009

  22. Instituto Mexicano del Seguro Social. Diagnóstico y Tratamiento Farmacológico de la diabetes mellitus tipo 2 en el primer nivel de atención. Guía de Evidencias y Recomendaciones: Guía de Práctica Clínica. México: IMSS, 2018 [citado septiembre 19, 2020]. Disponible en: http://www.imss. gob.mx/sites/all/statics/guiasclinicas/718GER.pdf

  23. Secretaría de Salud. Algoritmos de atención clínica. Diabetes mellitus tipo 2. Primer nivel de atención. Población de 18 a 79 años. Plan estratégico sectorial para la difusión e implementación de guías de práctica clínica mediante algoritmos de atención clínica. 2ª ed [citado septiembre 19, 2020]. Disponible en: http://educads.salud.gob.mx/sitio/recursos/DIABETES.pdf

  24. American Diabetes Association. 5. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S48-65. https://doi. org/10.2337/dc20-S005

  25. Franz MJ, MacLeod J, Evert A, Brown C, Gradwell E, Handu D, et al. Academy of Nutrition and Dietetics nutrition practice guideline for type 1 and type 2 diabetes in adults: Systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J Acad Nutr Dietet. 2017;117(10):1659-79. https://doi.org/10.1016/j.jand.2017.03.022

  26. Thorp AA, Kingwell BA, Sethi P, Hammond L, Owen N, Dunstan DW. Alternating bouts of sitting and standing attenuate postprandial glucose responses. Med Sci Sports Exerc. 2014;46(11):2053-61. https://doi. org/10.1249/MSS.0000000000000337

  27. Le P, Chaitoff A, Misra-Hebert AD, Ye W, Herman WH, Rothberg MB. Use of antihyperglycemic medications in US adults: an analysis of the National Health and Nutrition Examination Survey. Diabetes Care. 2020;43(6):1227-33. https://doi.org/10.2337/dc19-2424

  28. American Diabetes Association. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Suppl 1):S111-134. https://doi.org/10.2337/dc20-S010

  29. Denova-Gutiérrez E, Vargas-Chanes D, Hernández S, Muñoz- Aguirre P, Napier D, Barquera S. Linking socioeconomic inequalities and type 2 diabetes through obesity and lifestyle factors among Mexican adults: a structural equations modeling approach. Salud Publica Mex. 2020;62(2):192-202. https://doi.org/10.21149/10819




2020     |     www.medigraphic.com